NCT03616678 is a NA clinical trial of VenTouch System in Functional Mitral Regurgitation, sponsored by Mardil Medical.

Who is sponsoring NCT03616678?

NCT03616678 is sponsored by Mardil Medical.

What drugs are being tested in NCT03616678?

Interventions in NCT03616678: VenTouch System.

What condition does NCT03616678 study?

NCT03616678 studies Functional Mitral Regurgitation.

Is NCT03616678 still recruiting?

NCT03616678 is currently status unknown. Last updated 9 September 2020.

Last reviewed 2020-09-09 · How we verify

NCT03616678

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VenTouch OUS Feasibility Study

Status unknown NA Last updated 9 September 2020

What this trial tests

NA trial testing VenTouch System in Functional Mitral Regurgitation in 15 participants. Status unknown.

Timeline

25 March 2019

Primary endpoint
31 May 2021

31 December 2023

Quick facts

Lead sponsor	Mardil Medical
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	25 March 2019
Primary completion	31 May 2021
Estimated completion	31 December 2023
Sites	12 locations across France, Panama, Netherlands, Germany, Hungary, Poland, Canada

Drugs / interventions tested

VenTouch System

Conditions studied

Functional Mitral Regurgitation — all drugs for Functional Mitral Regurgitation →

Sponsor

Mardil Medical

Who can join

18 and older, any sex, with Functional Mitral Regurgitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, multi-center, single-arm study to evaluate safety and efficacy of the VenTouch System for treatment of subjects with functional MR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Functional Mitral Regurgitation

Currently open trials in the same condition.

NCT06823700 — Safety and Effectiveness Study of SQ-Kyrin System for Functional Mitral Regurgitation in EU · NA · recruiting
NCT05991284 — Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation · Phase 4 · active not recruiting
NCT05965258 — Phenotypic Classification of FMR With CMR · recruiting
NCT03929913 — NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study · NA · active not recruiting
NCT03706833 — Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial · NA · active not recruiting

Other Mardil Medical trials

Trials by the same sponsor.

NCT03228381 — The BOSS Study: An Acute Evaluation of Anatomical and Geometric Changes Using the Bladder on a Stick System (BOSS) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03616678 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mardil Medical
Last refreshed: 9 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03616678.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing